Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Alpha-d-galactose
2. Alpha-d-galactopyranose
3. 3646-73-9
4. Gal-alpha
5. 5abp
6. 8abp
7. Alpha-d-gal
8. Galactose (nf)
9. Chebi:28061
10. (2s,3r,4s,5r,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol
11. 7iof6h4h77
12. A-d-galactopyranose
13. .alpha.-d-galactopyranose
14. (2s,3r,4s,5r,6r)-6-(hydroxymethyl)tetrahydro-2h-pyran-2,3,4,5-tetraol
15. D-hexose
16. (+)-galactose
17. .alpha.-d-galactose
18. Galactose [usan:nf]
19. Unii-7iof6h4h77
20. Alphagal
21. Alpha-galactose
22. Mfcd00066772
23. Alpha-d-galactoside
24. I+/--d-galactose
25. 6-(hydroxymethyl)tetrahydropyran-2,3,4,5-tetraol
26. Bmse000013
27. Bmse001006
28. Epitope Id:136906
29. Schembl18314
30. Galactose (d-galactopyranose)
31. Gtpl4646
32. Chembl1233058
33. Dtxsid90189974
34. Zinc901155
35. Bdbm50423644
36. Akos006283213
37. D-galactose .alpha.-form [mi]
38. C00984
39. D04291
40. Q181381
41. Wurcs=2.0/1,1,0/[a2112h-1a_1-5]/1/
42. Alpha-d-galactose; D-galactose; Galactose; Alpha D-galactose
43. (2rs,3r,4s,5r,6r)-6-(hydroxymethyl)tetrahydropyran-2,3,4,5-tetrol
Molecular Weight | 180.16 g/mol |
---|---|
Molecular Formula | C6H12O6 |
XLogP3 | -2.6 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 1 |
Exact Mass | 180.06338810 g/mol |
Monoisotopic Mass | 180.06338810 g/mol |
Topological Polar Surface Area | 110 Ų |
Heavy Atom Count | 12 |
Formal Charge | 0 |
Complexity | 151 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
A Alpha-D-Galactose manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Alpha-D-Galactose, including repackagers and relabelers. The FDA regulates Alpha-D-Galactose manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Alpha-D-Galactose API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Alpha-D-Galactose manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Alpha-D-Galactose supplier is an individual or a company that provides Alpha-D-Galactose active pharmaceutical ingredient (API) or Alpha-D-Galactose finished formulations upon request. The Alpha-D-Galactose suppliers may include Alpha-D-Galactose API manufacturers, exporters, distributors and traders.
click here to find a list of Alpha-D-Galactose suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Alpha-D-Galactose DMF (Drug Master File) is a document detailing the whole manufacturing process of Alpha-D-Galactose active pharmaceutical ingredient (API) in detail. Different forms of Alpha-D-Galactose DMFs exist exist since differing nations have different regulations, such as Alpha-D-Galactose USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Alpha-D-Galactose DMF submitted to regulatory agencies in the US is known as a USDMF. Alpha-D-Galactose USDMF includes data on Alpha-D-Galactose's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Alpha-D-Galactose USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Alpha-D-Galactose suppliers with USDMF on PharmaCompass.
A Alpha-D-Galactose CEP of the European Pharmacopoeia monograph is often referred to as a Alpha-D-Galactose Certificate of Suitability (COS). The purpose of a Alpha-D-Galactose CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Alpha-D-Galactose EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Alpha-D-Galactose to their clients by showing that a Alpha-D-Galactose CEP has been issued for it. The manufacturer submits a Alpha-D-Galactose CEP (COS) as part of the market authorization procedure, and it takes on the role of a Alpha-D-Galactose CEP holder for the record. Additionally, the data presented in the Alpha-D-Galactose CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Alpha-D-Galactose DMF.
A Alpha-D-Galactose CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Alpha-D-Galactose CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Alpha-D-Galactose suppliers with CEP (COS) on PharmaCompass.
Alpha-D-Galactose Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Alpha-D-Galactose GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Alpha-D-Galactose GMP manufacturer or Alpha-D-Galactose GMP API supplier for your needs.
A Alpha-D-Galactose CoA (Certificate of Analysis) is a formal document that attests to Alpha-D-Galactose's compliance with Alpha-D-Galactose specifications and serves as a tool for batch-level quality control.
Alpha-D-Galactose CoA mostly includes findings from lab analyses of a specific batch. For each Alpha-D-Galactose CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Alpha-D-Galactose may be tested according to a variety of international standards, such as European Pharmacopoeia (Alpha-D-Galactose EP), Alpha-D-Galactose JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Alpha-D-Galactose USP).
LOOKING FOR A SUPPLIER?